Document is current

Article History

Received: 15 August 2024

Accepted: 25 November 2024

First Online: 3 December 2024

Declarations

:

: The authors assert that all procedures contributing to this study comply with the ethical standards and are approved by the National Research Ethics Commission (Comissão Nacional de Ética em Pesquisa), the University of São Paulo and the Federal University of Rio Grande do Sul ethics committees. The authors assert that all procedures contributing to this study also comply with the Helsinki Declaration of 1975, as revised in 2008.

: Dr. Rohde has received grant or research support from, served as a consultant to, and served on the speakers’ bureau of Abdi Ibrahim, Abbott, Aché, Adium, Apsen, Bial, Cellera, EMS, Hypera Pharma, Knight Therapeutics, Libbs, Medice, Novartis/Sandoz, Pfizer/Upjohn/Viatris, Shire/Takeda, and Torrent in the last three years. The ADHD and Juvenile Bipolar Disorder Outpatient Programs chaired by Dr Rohde have received unrestricted educational and research support from the following pharmaceutical companies in the last three years: Novartis/Sandoz and Shire/Takeda. Dr Rohde has received authorship royalties from Oxford Press and ArtMed. Dr. Kieling reported grants from the Centre for Addiction and Mental Health during the conduct of the study; is a Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq, Brazil) researcher and a UK Academy of Medical Sciences Newton Advanced Fellow; and is the founder of Wida. Dr. Caye reported personal fees from Knight Therapeutics outside the submitted work. Hoffmann is supported by the United States National Institutes of Health grant R01MH120482 under his post-doctoral fellowship at UFRGS and by the Wellcome Mental Health Data Prize, granted by the Wellcome Trust (grant number 84494R). Dr. Pan received payment or honoraria for lectures and presentations in educational events for Abbot, Libbs, Instituto Israelita de Pesquisa e Ensino Albert Einstein. He is the co-founder and a substantial shareholder of the MINDCHECK medical company, which develops measurement-based tools for mental health evaluations and clinical care. All other authors report no conflict of interest.